Citation: Lp. Rivory et al., TRACE ANALYSIS OF SN-38 IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 714(2), 1998, pp. 355-359
Authors:
HAAZ MC
DODDS HM
RIOU JF
RICHE C
RIVORY LP
ROBERT J
Citation: Mc. Haaz et al., IDENTIFICATION OF A NEW METABOLITE OF CPT-11 (IRINOTECAN) - BIOSYNTHESIS AND ACTIVATION TO SN-38 BY HUMAN HEPATIC MICROSOMES, Annals of oncology, 9, 1998, pp. 221-221
Authors:
RIVORY LP
CLARKE S
BISHOP JF
ODONNELL A
EMMETT L
FINDLAY M
Citation: Lp. Rivory et al., IRINOTECAN (CPT-11) - A PRELIMINARY INVESTIGATION OF THE RELATIONSHIPBETWEEN TROUGH CONCENTRATIONS OF THE ACTIVE METABOLITE, SN-38, AND TOXICITY, Annals of oncology, 9, 1998, pp. 222-222
Citation: Hm. Dodds et al., THE DETECTION OF PHOTODEGRADATION PRODUCTS OF IRINOTECAN (CPT-11, CAMPTO(R), CAMPTOSAR(R)), IN CLINICAL-STUDIES, USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ATMOSPHERIC-PRESSURE CHEMICAL-IONIZATION MASS-SPECTROMETRY, Journal of pharmaceutical and biomedical analysis, 17(4-5), 1998, pp. 785-792
Citation: Mc. Haaz et al., BIOSYNTHESIS OF AN AMINOPIPERIDINO METABOLITE OF IRINOTECAN PIPERIDINO)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECINE] BY HUMAN HEPATIC MICROSOMES, Drug metabolism and disposition, 26(8), 1998, pp. 769-774
Authors:
DODDS HM
HAAZ MC
RIOU JF
ROBERT J
RIVORY LP
Citation: Hm. Dodds et al., IDENTIFICATION OF A NEW METABOLITE OF CPT-11 (IRINOTECAN) - PHARMACOLOGICAL PROPERTIES AND ACTIVATION TO SN-38, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 578-583
Authors:
RIVORY LP
HAAZ MC
CANAL P
LOKIEC F
ARMAND JP
ROBERT J
Citation: Lp. Rivory et al., PHARMACOKINETIC INTERRELATIONSHIPS OF IRINOTECAN (CPT-11) AND ITS 3 MAJOR PLASMA METABOLITES IN PATIENTS ENROLLED IN PHASE-I II TRIALS/, Clinical cancer research, 3(8), 1997, pp. 1261-1266
Authors:
ROBERTS MS
WU ZY
RIVORY LP
SMITHERS BM
EGERTON WS
WEISS M
Citation: Ms. Roberts et al., RELATIVE DISPERSION OF INTRAVASCULAR TRANSIT TIMES DURING ISOLATED HUMAN LIMB PERFUSIONS FOR RECURRENT MELANOMA, British journal of clinical pharmacology, 44(4), 1997, pp. 347-351
Citation: Mc. Haaz et al., THE TRANSFORMATION OF IRINOTECAN (CPT-11) TO ITS ACTIVE METABOLITE SN-38 BY HUMAN LIVER-MICROSOMES - DIFFERENTIAL HYDROLYSIS FOR THE LACTONE AND CARBOXYLATE FORMS, Naunyn-Schmiedeberg's archives of pharmacology, 356(2), 1997, pp. 257-262
Citation: Hm. Dodds et al., PHOTODEGRADATION OF IRINOTECAN (CPT-11) IN AQUEOUS-SOLUTIONS - IDENTIFICATION OF FLUORESCENT PRODUCTS AND INFLUENCE OF SOLUTION COMPOSITION, Journal of pharmaceutical sciences, 86(12), 1997, pp. 1410-1416
Citation: Dg. Lecouteur et al., THE EFFECT OF OXIDATIVE INJURY ON HEPATOCELLULAR INFLUX OF LEUCINE INTHE RAT, HEPATOLOGY RESEARCH, 4(6), 1996, pp. 343-350
Citation: Lp. Rivory et al., EFFECTS OF LIPOPHILICITY AND PROTEIN-BINDING ON THE HEPATOCELLULAR UPTAKE AND HEPATIC DISPOSITION OF 2 ANTHRACYCLINES, DOXORUBICIN AND IODODOXORUBICIN, Cancer chemotherapy and pharmacology, 38(5), 1996, pp. 439-445
Authors:
DODDS HM
WALPOLE ET
RIVORY LP
STRONG RW
POND SM
Citation: Hm. Dodds et al., DISPOSITION OF EPIRUBICIN AFTER INTRAARTERIAL ADMINISTRATION IN LIPIODOL TO PATIENTS WITH HEPATOCELLULAR-CARCINOMA, Therapeutic drug monitoring, 18(5), 1996, pp. 537-543
Authors:
BOURZAT JD
VUILHORGNE M
RIVORY LP
ROBERT J
COMMERCON A
Citation: Jd. Bourzat et al., SEMISYNTHESIS OF RPR 121056A, A MAJOR METABOLITE OF IRINOTECAN (CPT-11), Tetrahedron letters, 37(35), 1996, pp. 6327-6330
Authors:
RIVORY LP
RIOU JF
HAAZ MC
SABLE S
VUILHORGNE M
COMMERCON A
POND SM
ROBERT J
Citation: Lp. Rivory et al., IDENTIFICATION AND PROPERTIES OF A MAJOR PLASMA METABOLITE OF IRINOTECAN (CPT-11) ISOLATED FROM THE PLASMA OF PATIENTS, Cancer research, 56(16), 1996, pp. 3689-3694
Citation: Lp. Rivory et al., CONVERSION OF IRINOTECAN (CPT-11) TO ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN (SN-38), BY HUMAN LIVER CARBOXYLESTERASE, Biochemical pharmacology, 52(7), 1996, pp. 1103-1111
Citation: D. Lecouteur et al., AGING, ACUTE OXIDATIVE INJURY AND HEPATOCELLULAR GLUCOSE-TRANSPORT INTHE RAT, HEPATOLOGY RESEARCH, 3(5), 1995, pp. 244-253
Citation: Lp. Rivory et al., PHARMACOKINETICS AND INTERCONVERSION OF THE CARBOXYLATE AND LACTONE FORMS OF IRINOTECAN (CPT-11) AND OF ITS METABOLITE SN-38 IN PATIENTS, European journal of cancer, 31A, 1995, pp. 956-956
Citation: Lp. Rivory et J. Robert, IDENTIFICATION AND KINETICS OF A BETA-GLUCURONIDE METABOLITE OF SN-38IN HUMAN PLASMA AFTER ADMINISTRATION OF THE CAMPTOTHECIN DERIVATIVE IRINOTECAN, Cancer chemotherapy and pharmacology, 36(2), 1995, pp. 176-179
Citation: Lp. Rivory et J. Robert, MOLECULAR, CELLULAR, AND CLINICAL ASPECTS OF THE PHARMACOLOGY OF 20(S)CAMPTOTHECIN AND ITS DERIVATIVES, Pharmacology & therapeutics, 68(2), 1995, pp. 269-296
Citation: Lp. Rivory et J. Robert, REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THESIMULTANEOUS QUANTITATION OF THE CARBOXYLATE AND LACTONE FORMS OF THECAMPTOTHECIN DERIVATIVE IRINOTECAN, CPT-11, AND ITS METABOLITE SN-38 IN PLASMA, Journal of chromatography B. Biomedical applications, 661(1), 1994, pp. 133-141
Citation: Dg. Lecouteur et al., GLUCOSE-TRANSPORT AND HYPOXIA-REOXYGENATION INJURY IN THE PERFUSED-RAT-LIVER, Journal of gastroenterology and hepatology, 9(4), 1994, pp. 385-390
Citation: Dg. Lecouteur et al., THE EFFECTS OF AGING AND NUTRITIONAL STATE ON HYPOXIA-REOXYGENATION INJURY IN THE PERFUSED-RAT-LIVER, Transplantation, 58(5), 1994, pp. 531-536